Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 2, 2009, Pages 175-179

  Sato, Eriko ^a   Yano, Ikuko ^a   Shimomuro, Masahiro ^a   Masuda, Satohiro ^a   Katsura, Toshiya ^a   Matsumoto, Shin Ichi ^a   Okitsu, Teru ^a   Iwanaga, Yasuhiro ^a   Uemoto, Shinji ^b   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Everolimus; Pancreatic islet transplantation; Sirolimus; Tacrolimus

Indexed keywords

EVEROLIMUS; RAPAMYCIN; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CROSS REACTION; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRAFT REJECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PANCREAS ISLET TRANSPLANTATION; RADIATION DETECTION; ULTRAVIOLET RADIATION;

EID: 67649342624     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.175     Document Type: Article

References (20)

1. Shapiro, A.M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M. and Rajotte, R. V.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med., 343: 230-238 (2000).
2. Matsumoto, S., Okitsu, T., Iwanaga, Y., Noguchi, H., Nagata, H., Yonekawa, Y., Yamada, Y., Fukuda, K., Tsukiyama, K., Suzuki, H., Kawasaki, Y., Shimodaira, M., Matsuoka, K., Shibata, T., Kasai, Y., Maekawa, T., Shapiro, J. and Tanaka, K.: Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet, 365: 1642-1644 (2005).
3. Neuhaus, P., Klupp, J. and Langrehr, J. M.: mTOR inhibitors: an overview. Liver Transpl., 7: 473-484 (2001).
4. Crowe, A., Bruelisauer, A., Duerr, L., Guntz, P. and Lemaire, M.: Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab. Dispos., 7: 627-632 (1999).
5. Kovarik, J. M., Kalbag, J., Figueiredo, J., Rouilly, M., Frazier, O. L. and Rordorf, C.: Differential influence of two cyclosporine formulations on everolimus pharmacokinetics: a clinically relevant pharmacokinetic interaction. J. Clin. Pharmacol., 42: 95-99 (2002).
6. Zimmerman, J. J., Harper, D., Getsy, J. and Jusko, W. J.: Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers. J. Clin. Pharmacol., 43: 1168-1176 (2003).
7. Jacobsen, W., Serkova, N., Hausen, B., Morris, R. E., Benet, L. Z. and Christians, U.: Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD. Transplant. Proc., 33: 514-515 (2001).
8. Crowe, A. and Lemaire, M.: In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm. Res., 15: 1666-1672 (1998).
9. Hebert, M. F.: Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv. Drug Deliv. Rev., 27: 201-214 (1997).
10. Sato, E., Shimomura, M., Masuda, S., Yano, I., Katsura, T., Matsumoto, S., Okitsu, T., Iwanaga, Y., Noguchi, H., Nagata, H., Yonekawa, Y. and Inui, K.: Temporal decline in sirolimus elimination immediately after pancreatic islet transplantation. Drug Metab. Pharmacokinet., 21: 492-500 (2006).
11. Kovarik, J. M., Kaplan, B., Silva, H. T., Kahan, B. D., Dantal, J., McMahon, L., Berthier, S., Hsu, C. H. and Rordorf, C.: Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation. Am. J. Transplant., 3: 606-613 (2003).
12. Kovarik, J. M., Dantal, J., Civati, G., Rizzo, G., Rouilly, M., Bettoni-Ristic, O. and Rordorf, C.: Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patients. Am. J. Transplant., 3: 1576-1580 (2003).
13. Kovarik, J. M., Curtis, J. J., Hricik, D. E., Pescovitz, M. D., Scantlebury, V. and Vasquez, A.: Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus. Transplant. Proc., 38: 3456-3458 (2006).
14. Wu, F. L., Tsai, M. K., Chen, R. R., Sun, S.W.,Huang, J. D., Hu, R. H., Chen, K. H. and Lee, P. H.: Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients. Pharmacotherapy, 25: 646-653 (2005).
15. Zimmerman, J. J., Lasseter, K. C., Lim, H. K., Harper, D., Dilzer, S. C., Parker, V. and Matschke, K.: Pharmacokinetics of sirolimus (rapamycin) in subjects with mild to moderate hepatic impairment. J. Clin. Pharmacol., 45: 1363-1372 (2005).
16. Kovarik, J. M., Kahan, B. D., Kaplan, B., Lorber, M., Winkler, M., Rouilly, M., Gerbeau, C., Cambon, N., Boger, R. and Rordorf, C. on behalf of the Everolimus Phase 2 Study Group.: Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Clin. Pharmacol. Ther., 69: 48-56 (2001).
17. Mabasa, V. H. and Ensom, M. H.: The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther. Drug Monit., 27: 666-676 (2005).
18. Strom, T., Haschke, M., Boyd, J., Roberts, M., Arabshahi, L., Marbach, P. and Christians, U.: Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus. Ther. Drug Monit., 29: 743-749 (2007).
19. Salm, P., Warnholtz, C., Boyd, J., Arabshahi, L., Marbach, P. and Taylor, P. J.: Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients. Clin. Biochem., 39: 732-738 (2006).
20. Khoschsorur, G., Fruehwirth, F., Zelzer, S., Stettin, M. and Halwachs-Baumann, G.: Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation. Clin. Chim. Acta., 380: 217-221 (2007).